Differences in intention to use flavored oral nicotine products among young adult e-cigarette users and non-users
- PMID: 36304078
- PMCID: PMC9594628
- DOI: 10.1016/j.pmedr.2022.102027
Differences in intention to use flavored oral nicotine products among young adult e-cigarette users and non-users
Abstract
New oral nicotine products (ONPs; nicotine pouches, gums, lozenges, and gummies), which are regulated as nonmedicinal tobacco products in the U.S., have flavors and other characteristics that previously attracted young adults to e-cigarettes. Whether young adults' interest in ONPs differs by e-cigarette use status and quit-vaping motivation is unknown but important for understanding the possible health impact of ONPs. It is particularly important to study if nonmedicinal ONPs attract e-cigarette users interested in quitting vaping, given that nicotine replacement (NRT) therapy uptake in young adults is low. In this study, ONP non-users (ages: 20-24) from California viewed digital images of 5 flavored ONPs (4 nonmedicinal and one NRT gum product) and reported intention to use each ONP (0-100 score). Main and interactive effects of Group (past-6-month e-cigarette non-users [n = 1,1388], e-cigarette users unmotivated to quit vaping [n = 168], and e-cigarette users motivated to quit vaping [n = 99]) and ONP type (nonmedicinal gum, nonmedicinal lozenge, gummy, pouch, and NRT gum) on use intention were tested. For each nonmedicinal ONP, use intention was higher in both e-cigarette user groups than non-users (ds = 0.47-0.59; Ps < 0.001), but did not differ between e-cigarette users with and without quit-vaping motivation (Ps ≥ 0.31). A Group × ONP type interaction was found, whereby higher use intention for e-cigarette users with vs without quit motivation was present for only gum NRT (Cohens d = 0.17; P =.01). Among young adults, e-cigarette users might be more inclined than e-cigarette non-users to try nonmedicinal ONPs regardless of quit-vaping motivation.
© 2022 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures


Similar articles
-
Young adults' beliefs about modern oral nicotine products: Implications for uptake in nonvapers, dual use with e-cigarettes, and use to reduce/quit vaping.Exp Clin Psychopharmacol. 2023 Apr;31(2):455-463. doi: 10.1037/pha0000595. Epub 2022 Sep 1. Exp Clin Psychopharmacol. 2023. PMID: 36048111 Free PMC article.
-
Oral Nicotine Product Use and Vaping Progression Among Adolescents.Pediatrics. 2025 Jun 1;155(6):e2024070312. doi: 10.1542/peds.2024-070312. Pediatrics. 2025. PMID: 40383543
-
Classification, Perception, and Toxicity of Emerging Flavored Oral Nicotine Pouches.Int J Environ Res Public Health. 2023 Mar 3;20(5):4526. doi: 10.3390/ijerph20054526. Int J Environ Res Public Health. 2023. PMID: 36901533 Free PMC article. Review.
-
Appeal and Sensory Characteristics of Oral Nicotine Products in Young Adults Who Vape E-Cigarettes.Nicotine Tob Res. 2024 Nov 28:ntae281. doi: 10.1093/ntr/ntae281. Online ahead of print. Nicotine Tob Res. 2024. PMID: 39607696
-
A comprehensive review on oral nicotine pouches: Available scientific evidence and future research needs.Exp Clin Psychopharmacol. 2025 Apr;33(2):123-132. doi: 10.1037/pha0000755. Epub 2024 Dec 2. Exp Clin Psychopharmacol. 2025. PMID: 39621395 Review.
Cited by
-
Tobacco-Free Nicotine Pouches and Their Potential Contribution to Tobacco Harm Reduction: A Scoping Review.Cureus. 2024 Feb 15;16(2):e54228. doi: 10.7759/cureus.54228. eCollection 2024 Feb. Cureus. 2024. PMID: 38496069 Free PMC article.
-
Prevalence and correlates of flavored novel oral nicotine product use among a national sample of youth.Addict Behav. 2024 May;152:107982. doi: 10.1016/j.addbeh.2024.107982. Epub 2024 Feb 10. Addict Behav. 2024. PMID: 38359494 Free PMC article.
References
-
- Azzopardi D., Liu C., Murphy J. Chemical characterization of tobacco-free “modern” oral nicotine pouches and their position on the toxicant and risk continuums. Drug Chem. Toxicol. 2021 - PubMed
-
- Babb S., Malarcher A., Schauer G., Asman K., Jamal A. Quitting smoking among adults— United States, 2000–2015. MMWR Morb Mortal Wkly Rep. 2017;65(52):1457–1464. - PubMed
-
- Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc.: Series B (Methodological). 1995;57(1):289–300.
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous